{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:09:29Z","timestamp":1778875769380,"version":"3.51.4"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["68752"],"award-info":[{"award-number":["68752"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.reth.2025.06.019","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T14:34:18Z","timestamp":1751985258000},"page":"351-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The role of telomeres in leukemic stem cells function"],"prefix":"10.1016","volume":"30","author":[{"given":"Raheleh","family":"Farahzadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behnaz","family":"Valipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0806-2735","authenticated-orcid":false,"given":"Ezzatollah","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakhavat","family":"Abolhasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reth.2025.06.019_bib2","doi-asserted-by":"crossref","first-page":"1410914","DOI":"10.3389\/fcell.2024.1410914","article-title":"Mechanism of LncRNA Gm2044 in germ cell development","volume":"12","author":"Zhu","year":"2024","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.reth.2025.06.019_bib3","first-page":"113","article-title":"Mesenchymal stem cells cause telomere length reduction of molt-4 cells via caspase-3, BAD and P53 apoptotic pathway","volume":"10","author":"Heidari","year":"2021","journal-title":"Int J Mol Cell Med"},{"issue":"3","key":"10.1016\/j.reth.2025.06.019_bib4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cell.2013.01.010","article-title":"The role of telomeres in stem cells and cancer","volume":"152","author":"G\u00fcnes","year":"2013","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.reth.2025.06.019_bib5","first-page":"71","article-title":"Mesenchymal stem cells as a cell-based therapeutic strategy targeting the telomerase activity of KG1 acute myeloid leukemia cells","volume":"60","author":"Fathi","year":"2022","journal-title":"Acta Med Iran"},{"issue":"5","key":"10.1016\/j.reth.2025.06.019_bib6","first-page":"199","article-title":"Targeting the proliferation inhibition of chronic myeloid leukemia cells by bone marrow derived-mesenchymal stem cells via ERK pathway as a therapeutic strategy","volume":"58","author":"Fathi","year":"2020","journal-title":"Acta Med Iran"},{"issue":"4","key":"10.1016\/j.reth.2025.06.019_bib7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cell.2011.12.028","article-title":"Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer","volume":"148","author":"Hu","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.reth.2025.06.019_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","article-title":"The origin and evolution of mutations in acute myeloid leukemia","volume":"150","author":"Welch","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.reth.2025.06.019_bib9","doi-asserted-by":"crossref","first-page":"914347","DOI":"10.3389\/fphar.2022.914347","article-title":"Synergistic effect of VEGF and SDF-1\u03b1 in endothelial progenitor cells and vascular smooth muscle cells","volume":"13","author":"Yang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.reth.2025.06.019_bib10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jconrel.2024.11.064","article-title":"An engineered \u03b11\u03b21 integrin-mediated Fc\u03b3RI signaling component to control enhanced CAR macrophage activation and phagocytosis","volume":"377","author":"Du","year":"2025","journal-title":"J Contr Release"},{"issue":"1","key":"10.1016\/j.reth.2025.06.019_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.15283\/ijsc.2016.9.1.107","article-title":"L-carnitine effectively induces hTERT gene expression of human adipose tissue-derived mesenchymal stem cells obtained from the aged subjects","volume":"9","author":"Farahzadi","year":"2016","journal-title":"Int J Stem Cells"},{"issue":"33","key":"10.1016\/j.reth.2025.06.019_bib12","article-title":"VEGF-FGF signaling activates quiescent CD63(+) liver stem cells to proliferate and differentiate","volume":"11","author":"Chen","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"10.1016\/j.reth.2025.06.019_bib13","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1634\/stemcells.2007-0057","article-title":"Concise review: telomere biology in normal and leukemic hematopoietic stem cells","volume":"25","author":"Drummond","year":"2007","journal-title":"Stem Cell"},{"issue":"9","key":"10.1016\/j.reth.2025.06.019_bib14","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.stem.2024.06.007","article-title":"Nynrin preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore opening","volume":"31","author":"Zhou","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.reth.2025.06.019_bib15","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1038\/s41375-024-02423-3","article-title":"Essential role of Dhx16-mediated ribosome assembly in maintenance of hematopoietic stem cells","volume":"38","author":"Li","year":"2024","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.reth.2025.06.019_bib16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1146\/annurev.immunol.21.120601.141007","article-title":"Biology of hematopoietic stem cells and progenitors: implications for clinical application","volume":"21","author":"Kondo","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.reth.2025.06.019_bib17","doi-asserted-by":"crossref","first-page":"2713483","DOI":"10.1155\/2022\/2713483","article-title":"Cellular and molecular mechanisms involved in hematopoietic stem cell aging as a clinical prospect","volume":"2022","author":"Montazersaheb","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.reth.2025.06.019_bib18","doi-asserted-by":"crossref","first-page":"11842","DOI":"10.1073\/pnas.2034201100","article-title":"Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?","volume":"100","author":"Passegu\u00e9","year":"2003","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"10.1016\/j.reth.2025.06.019_bib19","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1021\/acs.jmedchem.3c02232","article-title":"Three rounds of stability-guided optimization and systematical evaluation of oncolytic peptide LTX-315","volume":"67","author":"Fu","year":"2024","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.reth.2025.06.019_bib20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.stem.2024.04.021","article-title":"Modified lentiviral globin gene therapy for pediatric \u03b2(0)\/\u03b2(0) transfusion-dependent \u03b2-thalassemia: a single-center, single-arm pilot trial","volume":"31","author":"Li","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.reth.2025.06.019_bib21","doi-asserted-by":"crossref","first-page":"104726","DOI":"10.1016\/j.phrs.2020.104726","article-title":"Telomerase: key regulator of inflammation and cancer","volume":"155","author":"Wu","year":"2020","journal-title":"Pharmacol Res"},{"issue":"5","key":"10.1016\/j.reth.2025.06.019_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41576-019-0099-1","article-title":"Telomeres and telomerase: three decades of progress","volume":"20","author":"Shay","year":"2019","journal-title":"Nat Rev Genet"},{"issue":"6","key":"10.1016\/j.reth.2025.06.019_bib23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2174\/1568026620666200106145340","article-title":"Telomere-related markers for cancer","volume":"20","author":"Yuan","year":"2020","journal-title":"Curr Top Med Chem"},{"issue":"6","key":"10.1016\/j.reth.2025.06.019_bib24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3390\/biom10060873","article-title":"Human telomerase RNA: telomerase component or more?","volume":"10","author":"Rubtsova","year":"2020","journal-title":"Biomolecules"},{"issue":"6464","key":"10.1016\/j.reth.2025.06.019_bib25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.reth.2025.06.019_bib26","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.reth.2025.06.019_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/bjh.16044","article-title":"SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation","volume":"187","author":"Ma","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.reth.2025.06.019_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.775128","article-title":"Leukemic stem cells: from leukemic niche biology to treatment opportunities","volume":"12","author":"Marchand","year":"2021","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"10.1016\/j.reth.2025.06.019_bib29","first-page":"7","article-title":"The relationship between the spleen colony-forming cell and the haemopoietic stem cell","volume":"4","author":"Schofield","year":"1978","journal-title":"Blood cells"},{"issue":"5","key":"10.1016\/j.reth.2025.06.019_bib30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41580-019-0103-9","article-title":"Haematopoietic stem cell activity and interactions with the niche","volume":"20","author":"Pinho","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.reth.2025.06.019_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone marrow niches in haematological malignancies","volume":"20","author":"M\u00e9ndez-Ferrer","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.reth.2025.06.019_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5045\/br.2020.55.1.10","article-title":"A general view of CD33(+) leukemic stem cells and CAR-T cells as interesting targets in acute myeloblatsic leukemia therapy","volume":"55","author":"Fathi","year":"2020","journal-title":"Blood Res"},{"issue":"9","key":"10.1016\/j.reth.2025.06.019_bib33","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm.2415","article-title":"Stem cell gene expression programs influence clinical outcome in human leukemia","volume":"17","author":"Eppert","year":"2011","journal-title":"Nat Med"},{"issue":"7488","key":"10.1016\/j.reth.2025.06.019_bib34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature13038","article-title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.reth.2025.06.019_bib35","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3923\/ijp.2024.1163.1180","article-title":"Research article potential chemotherapeutic effect of coenzyme Q10 against liver injury in a leukemia rat model by 7, 12-dimethylbenz [a] anthracene","volume":"20","author":"Alshali","year":"2024","journal-title":"Int J Pharmacol"},{"issue":"6465","key":"10.1016\/j.reth.2025.06.019_bib36","doi-asserted-by":"crossref","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.reth.2025.06.019_bib37","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.stem.2019.07.001","article-title":"Interconversion between tumorigenic and differentiated states in acute myeloid leukemia","volume":"25","author":"McKenzie","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"16","key":"10.1016\/j.reth.2025.06.019_bib38","first-page":"2018","article-title":"GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo","volume":"127","author":"Pabst","year":"2016","journal-title":"Blood, J Am Soci Hematol"},{"issue":"5","key":"10.1016\/j.reth.2025.06.019_bib39","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/cancers12051174","article-title":"CD34+ CD38\u2212 CD123+ leukemic stem cell frequency predicts outcome in older acute myeloid leukemia patients treated by intensive chemotherapy but not hypomethylating agents","volume":"12","author":"Vergez","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.reth.2025.06.019_bib40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bjh.13572","article-title":"Absence of leukaemic CD 34+ cells in acute myeloid leukaemia is of high prognostic value: a longstanding controversy deciphered","volume":"171","author":"Zeijlemaker","year":"2015","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.reth.2025.06.019_bib41","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41375-018-0326-3","article-title":"CD34+ CD38\u2212 leukemic stem cell frequency to predict outcome in acute myeloid leukemia","volume":"33","author":"Zeijlemaker","year":"2019","journal-title":"Leukemia"},{"issue":"7633","key":"10.1016\/j.reth.2025.06.019_bib42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"Ng","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.reth.2025.06.019_bib43","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/s41467-021-22625-y","article-title":"A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia","volume":"12","author":"Docking","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.reth.2025.06.019_bib44","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.stem.2010.11.014","article-title":"TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells","volume":"7","author":"Kikushige","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"25","key":"10.1016\/j.reth.2025.06.019_bib45","doi-asserted-by":"crossref","first-page":"13782","DOI":"10.1073\/pnas.94.25.13782","article-title":"In vivo telomere dynamics of human hematopoietic stem cells","volume":"94","author":"Notaro","year":"1997","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.reth.2025.06.019_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2001.tb03568.x","article-title":"Limited telomere shortening in hematopoietic stem cells after transplantation","volume":"938","author":"Br\u00fcmmendorf","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.reth.2025.06.019_bib47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2011.06.004","article-title":"Telomere biology in hematopoiesis and stem cell transplantation","volume":"25","author":"Gadalla","year":"2011","journal-title":"Blood Rev"},{"key":"10.1016\/j.reth.2025.06.019_bib48","doi-asserted-by":"crossref","first-page":"113392","DOI":"10.1016\/j.intimp.2024.113392","article-title":"Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies","volume":"144","author":"Sun","year":"2025","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"10.1016\/j.reth.2025.06.019_bib49","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1182\/blood-2003-09-3079","article-title":"Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication","volume":"103","author":"Gammaitoni","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.reth.2025.06.019_bib50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2141.2003.04043.x","article-title":"Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapy","volume":"120","author":"Szyper-Kravitz","year":"2003","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.reth.2025.06.019_bib51","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nm0403-369","article-title":"Effect of TERT over-expression on the long-term transplantation capacity of hematopoietic stem cells","volume":"9","author":"Allsopp","year":"2003","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.reth.2025.06.019_bib52","first-page":"3093","article-title":"Telomere length and hematological disorders: a review. In Vivo","volume":"34","author":"Nogueira","year":"2020","journal-title":"(Athens)"},{"key":"10.1016\/j.reth.2025.06.019_bib53","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.leukres.2017.02.002","article-title":"Telomerase and telomere biology in hematological diseases: a new therapeutic target","volume":"56","author":"Allegra","year":"2017","journal-title":"Leuk Res"},{"issue":"25","key":"10.1016\/j.reth.2025.06.019_bib54","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/bloodadvances.2017012112","article-title":"Maintenance of telomere length in AML","volume":"1","author":"Lansdorp","year":"2017","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.reth.2025.06.019_bib55","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/ijms19020606","article-title":"Telomere length maintenance in cancer: at the crossroad between telomerase and alternative lengthening of telomeres (ALT)","volume":"19","author":"De Vitis","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.reth.2025.06.019_bib56","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41580-020-0234-z","article-title":"Regulation of human telomerase in homeostasis and disease","volume":"21","author":"Roake","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.reth.2025.06.019_bib57","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.exphem.2010.10.008","article-title":"Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias","volume":"39","author":"Capraro","year":"2011","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1016\/j.reth.2025.06.019_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5507\/bp.2018.084","article-title":"Telomere dynamics in adult hematological malignancies","volume":"163","author":"Olbertova","year":"2019","journal-title":"Biomed Pap"},{"issue":"23","key":"10.1016\/j.reth.2025.06.019_bib59","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.reth.2025.06.019_bib60","first-page":"417","article-title":"Delineation of yet unknown cryptic subtelomere aberrations in 50% of acute myeloid leukemia with normal GTG-banding karyotype","volume":"34","author":"Gross","year":"2009","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.reth.2025.06.019_bib61","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<5::AID-AJH2>3.0.CO;2-4","article-title":"Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia","volume":"61","author":"Boultwood","year":"1999","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.reth.2025.06.019_bib62","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1593\/neo.09836","article-title":"Individual telomere lengths in chronic myeloid leukemia","volume":"11","author":"Samassekou","year":"2009","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.reth.2025.06.019_bib63","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/sj.leu.2400560","article-title":"Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression","volume":"11","author":"Ohyashiki","year":"1997","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.reth.2025.06.019_bib64","first-page":"2391","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood, J Am Soci Hematol"},{"issue":"8","key":"10.1016\/j.reth.2025.06.019_bib65","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3109\/10428194.2011.568648","article-title":"Telomere length in myelodysplastic syndromes","volume":"52","author":"Rollison","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.reth.2025.06.019_bib66","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ccell.2015.04.007","article-title":"Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome","volume":"27","author":"Colla","year":"2015","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.reth.2025.06.019_bib67","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/leu.2015.217","article-title":"Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial","volume":"29","author":"Strefford","year":"2015","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.reth.2025.06.019_bib68","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.3324\/haematol.2016.142968","article-title":"ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset# 2 is associated with markedly short telomeres","volume":"101","author":"Navrkalova","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.reth.2025.06.019_bib69","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3324\/haematol.2011.049874","article-title":"Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes","volume":"97","author":"Rampazzo","year":"2012","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.reth.2025.06.019_bib70","first-page":"1184","article-title":"Telomere length in mantle cell lymphoma","volume":"121","author":"Jebaraj","year":"2013","journal-title":"Blood, J Am Soci Hematol"},{"issue":"2","key":"10.1016\/j.reth.2025.06.019_bib71","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ijrobp.2007.01.050","article-title":"Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin\u2019s lymphoma prior to any treatment are predictive of second cancers","volume":"68","author":"M\u2019kacher","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.reth.2025.06.019_bib72","doi-asserted-by":"crossref","first-page":"1432869","DOI":"10.3389\/fonc.2024.1432869","article-title":"Evaluation of a three-gene methylation model for correlating lymph node metastasis in postoperative early gastric cancer adjacent samples","volume":"14","author":"Chen","year":"2024","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.reth.2025.06.019_bib73","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1593\/tlo.12142","article-title":"Three-dimensional telomere signatures of Hodgkin-and Reed-Sternberg cells at diagnosis identify patients with poor response to conventional chemotherapy","volume":"5","author":"Knecht","year":"2012","journal-title":"Transl Oncol"},{"issue":"1\u20132","key":"10.1016\/j.reth.2025.06.019_bib74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/10428199809050942","article-title":"Telomerase activity in Hodgkin\u2019s disease","volume":"30","author":"Brousset","year":"1998","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.reth.2025.06.019_bib75","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3390\/cancers10060169","article-title":"The transition between telomerase and alt mechanisms in Hodgkin lymphoma and its predictive value in clinical outcomes","volume":"10","author":"M\u2019kacher","year":"2018","journal-title":"Cancers"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235232042500152X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235232042500152X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:23:35Z","timestamp":1778873015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235232042500152X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":74,"alternative-id":["S235232042500152X"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2025.06.019","relation":{},"ISSN":["2352-3204"],"issn-type":[{"value":"2352-3204","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of telomeres in leukemic stem cells function","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2025.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier BV on behalf of The Japanese Society for Regenerative Medicine.","name":"copyright","label":"Copyright"}]}}